Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies

Experimental & Molecular Medicine
Aaron Ciechanover, Yong Tae Kwon

Abstract

Mammalian cells remove misfolded proteins using various proteolytic systems, including the ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy (CMA) and macroautophagy. The majority of misfolded proteins are degraded by the UPS, in which Ub-conjugated substrates are deubiquitinated, unfolded and cleaved into small peptides when passing through the narrow chamber of the proteasome. The substrates that expose a specific degradation signal, the KFERQ sequence motif, can be delivered to and degraded in lysosomes via the CMA. Aggregation-prone substrates resistant to both the UPS and the CMA can be degraded by macroautophagy, in which cargoes are segregated into autophagosomes before degradation by lysosomal hydrolases. Although most misfolded and aggregated proteins in the human proteome can be degraded by cellular protein quality control, some native and mutant proteins prone to aggregation into β-sheet-enriched oligomers are resistant to all known proteolytic pathways and can thus grow into inclusion bodies or extracellular plaques. The accumulation of protease-resistant misfolded and aggregated proteins is a common mechanism underlying protein misfolding disorders, including neurodegenerative diseases such as Hu...Continue Reading

References

Jan 1, 1991·Acta Neuropathologica·J W BoellaardH Diringer
Sep 14, 1991·The Veterinary Record·J M WyattJ W Wilesmith
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G PerryV Chau
Oct 31, 1987·The Veterinary Record·G A WellsR Bradley
Oct 16, 1986·The New England Journal of Medicine·E LugaresiP Gambetti
Sep 2, 1967·Nature·J S Griffith
Oct 1, 1982·Journal of Wildlife Diseases·E S Williams, S Young
Aug 25, 1995·The Journal of Biological Chemistry·L GregoriD Goldgaber
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·S K DebBurmanS Lindquist
Jun 11, 1998·The Biochemical Journal·K B HendilK Tanaka
Oct 6, 1998·Annual Review of Biochemistry·A Hershko, A Ciechanover
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·S B Prusiner
Dec 29, 1998·The Journal of Cell Biology·J A JohnstonR R Kopito
Nov 24, 1999·The Journal of Biological Chemistry·M C BennettM M Mouradian
May 9, 2000·The Journal of Biological Chemistry·N TanahashiK Tanaka
Dec 21, 2000·Trends in Cell Biology·R R Kopito
Jan 4, 2001·Neuroscience Letters·K S McNaught, P Jenner
Apr 30, 2002·Human Molecular Genetics·Brinda RavikumarDavid C Rubinsztein
Dec 14, 2002·Science·Chang-Wei LiuPhilip J Thomas
Jan 4, 2003·Nature Reviews. Neuroscience·Claudio Soto
Jan 29, 2003·The Journal of Biological Chemistry·Heather SnyderBenjamin Wolozin
Feb 19, 2003·Journal of Alzheimer's Disease : JAD·Ravi Shankar MishraNeena Singh
Apr 30, 2003·The Journal of Biological Chemistry·Julie L WebbDavid C Rubinsztein
Jul 23, 2003·Nature Biotechnology·Junmin PengSteven P Gygi
Jul 31, 2003·Proceedings of the National Academy of Sciences of the United States of America·T Chris GamblinVincent L Cryns
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy

❮ Previous
Next ❯

Citations

Feb 10, 2016·Frontiers in Molecular Neuroscience·Bing GongChristopher Cardozo
Jul 22, 2015·Mitochondrion·Davide Alessandro Basello, Anna Ivana Scovassi
Sep 5, 2015·Current Opinion in Biotechnology·Lauren Popp, Laura Segatori
Jan 26, 2016·Neural Regeneration Research·Michaeline Hebron, Charbel E-H Moussa
Nov 18, 2015·Journal of Molecular Neuroscience : MN·Paola RusminiAngelo Poletti
Oct 27, 2015·Frontiers in Molecular Biosciences·Nadinath B Nillegoda, Bernd Bukau
Feb 18, 2016·Molecules and Cells·Kang-Eun LeeCheol-Sang Hwang
Apr 2, 2016·Brain Research·Céline Ruegsegger, Smita Saxena
Mar 31, 2016·Journal of Cellular and Molecular Medicine·Kundlik GadhaveMaria Balea
Sep 22, 2015·Frontiers in Molecular Neuroscience·Romina J Gentier, Fred W van Leeuwen
Apr 12, 2016·Brain Research·Sonam Parakh, Julie D Atkin
Jun 7, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Priscilla De RosaEnza Maria Valente
Jul 21, 2015·Biochimie·Kamlesh Kumar SahuJack A Tuszynski
May 11, 2016·Trends in Pharmacological Sciences·Christian Behl
May 19, 2016·The New England Journal of Medicine·Paul NioiKari Stefansson
Jun 15, 2016·Analytical Biochemistry·Sucharita BhattacharyyaAndreas Matouschek
Jun 29, 2016·Nature Cell Biology·Norbert VolkmarJohn C Christianson
Jul 2, 2016·Science·David BalchinF Ulrich Hartl
Jul 6, 2016·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Masahiro SatoHiroshi Katsuki
Jul 19, 2016·Autophagy·Marta PajaresAntonio Cuadrado
Aug 4, 2016·Ageing Research Reviews·Maria Xilouri, Leonidas Stefanis
Oct 22, 2016·European Journal of Medicinal Chemistry·Hena Khanam Shamsuzzaman
Aug 16, 2016·Journal of Neural Transmission·Song LiWeidong Le
Jun 30, 2016·ACS Chemical Neuroscience·K RajasekharT Govindaraju
Oct 28, 2016·Cell Systems·Christopher M RoseSteven P Gygi
Sep 24, 2016·Wiley Interdisciplinary Reviews. RNA·Laura De ContiEmanuele Buratti
Oct 19, 2016·Expert Review of Neurotherapeutics·Charbel Moussa
Feb 6, 2017·Biochimica Et Biophysica Acta. General Subjects·Kyle S HoffmanChristopher J Brandl
Apr 11, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Amir Tayaranian Marvian, Dina Morshedi
Dec 3, 2016·Nucleic Acids Research·Kyle S HoffmanPatrick O'Donoghue
May 10, 2016·International Journal of Biological Macromolecules·Kinjal A PatelIpsita Roy
Jun 3, 2017·Autoimmunity Reviews·Sylviane MullerHélène Jeltsch-David

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
deubiquitination
lipidation
transgenic

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.